Licensing
Antiviral Emulsions™ is seeking discussions with qualified organizations interested in licensing, strategic partnerships, joint development, or acquisition of its patented surface technology platform.
Request NDAOpportunity Overview
- Technology Licensing
- Strategic Partnerships
- Joint Development
- Technology Acquisition
Commercial Development Strategy
The technology platform is being made available for commercial evaluation by organizations with expertise in material science, product development, manufacturing, and commercialization. Discussions may include licensing arrangements, collaborative development, regional rights, or acquisition opportunities.
Technology Licensing
Field-specific, exclusive, or non-exclusive licensing structures may be considered based on the commercial opportunity.
Strategic Partnerships
Collaboration with manufacturers, technology companies, and product developers for commercialization.
Joint Development
Co-development opportunities for application-specific validation, engineering, and market development.
Technology Acquisition
Organizations interested in acquiring the intellectual property portfolio are encouraged to begin confidential discussions.
Typical Review Process
Initial Discussion
Mutual NDA
Technical Review
Commercial Evaluation
Begin a Confidential Discussion
Organizations interested in licensing, strategic partnerships, or acquisition opportunities may request confidential access to the technical documentation package.
Request NDA